Coronavirus (COVID-19) Update
AmerisourceBergen and our global businesses are highly engaged during the ongoing spread of the novel COVID-19 “Coronavirus."

March 31, 2016

US Bioservices is Dispensing TETRABENAZINE, generic therapy for Huntington’s chorea

Through a partnership with Kadmon Pharmaceuticals, LLC, and Camber Pharmceuticals, Inc., US Bioservices is now dispensing TETRABENAZINE. This generic version of XENAZINE, which launched February 11, 2016, provides a lower-cost alternative to treat chorea (involuntary movements) associated with Huntington’s disease (HD).